Results 241 to 250 of about 19,278,296 (355)

Why We Need to Study Assisted Methods to Teach Typing to Nonspeaking Autistic People

open access: yesAutism Research, EarlyView.
ABSTRACT At least one third of autistic people have limited or no speech. Most nonspeaking autistic people are never provided alternatives that would enable the full range of expression that speech allows, significantly limiting their access to educational, social, and employment opportunities.
Vikram K. Jaswal   +4 more
wiley   +1 more source

A socio-ecological approach to the determinants of animal health management: A scoping review. [PDF]

open access: yesPLoS One
Vors L   +5 more
europepmc   +1 more source

Optimizing biomass use for carbon storage and land use with the OptiBiU model

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Optimal biomass use in a circular bioeconomy requires a system perspective to guide decision‐making. The Optimizing Biomass Use (OptiBiU) model was developed for this purpose. The model distinguishes among primary biomass production, intermediate products, and biobased products, and incorporates recycling.
Pim M. Post   +8 more
wiley   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy